Fig. 3From: Representativeness of European clinical trial populations in mild Alzheimer’s disease dementia: a comparison of 18-month outcomes with real-world data from the GERAS observational studyChange in Neuropsychiatric Inventory-12 score (propensity score-adjusted). *p < 0.05 for difference between study type at 12 months; p = 0.1882 for overall difference between study type; p = 0.1580 for study type × visit interaction. EU EuropeanBack to article page